30 January 2024


Patient centered and interoperable registry hub for Rare Neuromuscular Diseases


A recognised challenge for rare diseases is the heterogeneity of legacy data sets and the multiplicity of existing registries. EURO- NMD health care providers and patient organizations are currently active in more than 120, mostly disease specific and patient run registries.

While the existing registries are collecting important information, none of them is used by all EURO-NMD centres and there is no unified NMD or NMD Disease Specific Registry in EU.


The ERN EURO-NMD Registry

The Euro-NMD Registry is a web-based platform designed in RedCap and hosted by the Universitäts Klinikum Freiburg. It intends to collect data from all neuromuscular patients seen by the 82 HCPs participating in the Euro-NMD network.

In parallel, existing disease-specific registries can participate in the Registry Hub. This FAIR-based infrastructure allows federated queries to be run across all the different datasets and return aggregate results for all the registries connected through the Hub.

The EURO-NMD Registry enables uniform data capture and sharing across all network members through regulated Data Access Policy. It is designed to improve the prevention, diagnosis and treatment of Neuromuscular Disorders.


Aims of the ERN EURO-NMD Registry

The Registry’s primary aim is to support our patients’ care and guarantee the delivery of the highest standards of diagnosis and treatment across Europe while providing follow-up and improved management for undiagnosed patients.
At the same time, the Registry enables research opportunities for clinical trials, translational research and epidemiological studies, increasing patients’ access to research and knowledge generation.

  • Pseudo-anonymised data collection for all the patients seen within the network by each of the 82 healthcare providers that compose EURO-NMD
  • The possibility of aggregating existing data sources for neuromuscular diseases to our data collection, with or without data transfer per existing regulations, namely GDPR. The Registry Hub guarantees the data analysis, without data transfer, from different data sources, connected via data FAIR points, under regulated access as detailed in the Data Access Policy (INSERT LINK)
  • Provide an user-friendly platform simplifying data entry tasks with time-saving customisation of the workflow by branching logics
  • Collection of demographic data helping to build a clearer epidemiological picture for Neuromuscular Disorders in Europe.
  • Identification of patient-cohorts for clinical research, namely participation in clinical trials.
  • Natural history with deep phenotyping and continuous longitudinal real world data collection for specific neuromuscular diseases subsets.
  • Monitoring of care delivery by  Key Performance Indicators based on clinical and patient outcome measures.

Sets of data items in the ERN EURO-NMD Registry

The registry has three data levels:

  1. EU-CDEs: these are the set of Common Data Elements that were chosen by the Joint Research Centre and the European Platform on Rare Disease Registration for collection by all the European Reference Networks. These CDEs need to be collected once per year for each patient seen at the EURO-NMD’s healthcare providers.
  2. NMD-CDEs: this dataset contains all the cross-neuromuscular data elements that are useful for any neuromuscular condition. This dataset is recommended but not mandatory until 2026.
  3. DS-DEs: disease specific data elements are fields specific for each condition or group of conditions, as defined by the 5 working groups.

 

 


Why EURO-NMD Registry Hub?

  • The EURO-NMD registry is connected to what is called ‘EURO-NMD Registry Hub’ through an interoperability layer
  • The Hub provides an entry point to other neuromuscular registries that follow the FAIR data stewardship principles and enable GDPR-compliant information exchange
  • Four national or disease-specific patient registries are interoperable with the EURO-NMD Registry, allowing for federated analysis across these different resources.
  • Collectively, the Registry Hub brings together data that are currently siloed andfragmented to improve healthcare and advance research for neuromuscular diseases.
  • The EURO-NMD Registry Hub is designed as a clinician-patient partnership.


Registry Governance

Coordinator Teresinha Evangelista APHP Hôpital Pitié Salpêtrière, Paris, France
Clinical Advisor António Atalaia APHP Hôpital Pitié Salpêtrière, Paris, France
Project Manager Carla D’Angelo APHP Hôpital Pitié Salpêtrière, Paris, France
Co-Coordinator Janbernd Kirschner Medical Center – University of Freiburg, Germany
Data Manager Dagmar Wandrei Medical Center – University of Freiburg, Germany
IT Helpdesk Dagmar Wandrei Medical Center – University of Freiburg, Germany
IT Lead Adrian Tassoni Medical Center – University of Freiburg, Germany
Interoperability and FAIRification Lead Peter-Bram t’Hoen RadboudUMC, Netherlands
Interoperability and FAIRification, FAIR Data Steward Nawel Lalout RadboudUMC, Netherlands

The registry is governed by a Registry Steering Committee composed by the EURO-NMD Coordinator and Members of the EURO-NMD Registry Consortium. The Registry Steering Committee works closely with the EURO-NMD Executive Committee where each thematic working group of the network is represented.


Registry Quick Start Guide

Learn how to use the essential features of the Registry: (UNDER CONSTRUCTION)


Registry Documentation

Registry paper: “EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders”

Registry Governance

Data Security Policy

Data Sharing Agreement

Informed Consent Form in English

Data Access Policy

Publication Policy


Registry Data Access Requests

Find here the Data Access Policy of the EURO-NMD Registry: click to open in a new tab

Form to request access to data: click here to open in a new tab (UNDER CONSTRUCTION)

Data Acess Committe Feedback form: click here to open in a new tab (UNDER CONSTRUCTION)

For other queries use our helpdesk email address please: registryhelpdesk.euronmd@outlook.com


Registry Onboarding

Click here to open Registry Onboarding information in a new tab (UNDER CONSTRUCTION)


Find out more on the dedicated registry website.


 

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission


“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit ec.europa.eu/health/ern